Enanta Pharmaceuticals, Inc. ENTA
10.33 USD -0.39 -3.59%
As of Nov 2, 2:50 PM ET
10.15 52-week range 17.15
- YTD
- -34.53%
- 1 year
- -5.79%
- Open
- 10.74
- Prev close
- 10.71
- Mkt cap
- 300.14M
- Vol
- 146.20K
- Avg vol
- 248.63K
- EPS
- -2.42
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 10.15
- High
- 10.86
- Forward P/E
- -1.32
- Beta
- 0.57
- Short ratio
- 20.91
- Inst. own
- 100.66%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Feb 5, 2025
- 50-d avg
- 9.78
- 200-d avg
- 12.44
- 1y target
- 16.88
MAX chart
Chart tools
Chart is warming up
The all-time price history for ENTA has not been loaded yet. Try again in a moment.
Altman Z-Score
-0.90 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
3 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C-1 / 5 overall
- DCF 1
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 2
- P/E 1
- P/B 2
P/E -3.1×
P/S 3.9×
P/B 3.9×
P/FCF -7.9×
EV/EBITDA -6.0×
EV/Sales 6.5×
FCF Yield -12.6%
Gross Margin 93.0%
Operating Margin -130.7%
Net Margin -125.4%
ROE -126.5%
ROIC -31.4%
ROA -29.2%
Revenue -3.4%
Operating Income 29.9%
EPS (diluted) 29.9%
Free Cash Flow 66.7%
Current Ratio 4.2×
Quick Ratio 4.2×
Debt / Equity 3.1×
Net Debt / EBITDA -2.4×
Interest Coverage -11.1×
Dividend Yield 0.0%
Payout Ratio 0.0%
Annual · latest fiscal year ends 2025-09-30